CompletedNCT02435030
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
Studying Niemann-Pick disease type C
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ZevraDenmark
- Principal Investigator
- Karl-Eugen MengelVilla Metabolica, Mainz, Germany
- Enrollment
- 35 enrolled
- Eligibility
- 2-18 years · All sexes
- Timeline
- 2015 – 2017
Study locations (16)
- University Hospital Copenhagen (Rigshospitalet), Copenhagen, Denmark
- CHU de Montpellier, Montpellier, France
- Hôpital Trousseau, Paris, France
- Villa Metabolica Mainz, Mainz, Germany
- Klinikum der Universistat, Munchen, Munich, Germany
- Istituto Carlo Besta (Milano), Milan, Italy
- Azienda Ospedaliera San Gerardo, Monza, Italy
- Università Federico II, Naples, Italy
- Ospedale Pediatrico Bambino Gesù, Rome, Italy
- Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia", Udine, Italy
- The Children´s Memorial Istitute Warsaw, Warsaw, Poland
- Hospital Vall D'Hebron, Barcelona, Spain
- Hospital Quirón, Zaragoza, Spain
- Inselspital, University Hospital Bern, Bern, Switzerland
- Birmingham Children's Hospital, Birmingham, United Kingdom
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02435030 on ClinicalTrials.govOther trials for Niemann-Pick disease type C
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05588167Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type CEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- RECRUITINGPHASE3NCT05163288A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type CIntraBio Inc
- ACTIVE NOT RECRUITINGPHASE3NCT04860960Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1Cyclo Therapeutics, Inc.
- RECRUITINGNANCT00344331Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type CEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)